Disease Areas
Renalytix, Partners Launch $10M Consortium to Develop Kidney Disease Drug Response Tests
Renalytix said it will receive about $1 million in consortium funding to oversee commercial translation activities around the tests.
New Study Results Boost Evidence for Natera's MRD Assays to Guide Adjuvant Therapy Decisions
Premium
The data, from a large prospective cohort, support the value of chemotherapy for ctDNA-positive patients, regardless of clinical stage.
Geneoscopy Submits PMA Application to FDA for Stool-Based Colorectal Cancer Screening Test
The application is supported by data from the company's prospective trial, demonstrating 94 percent sensitivity for CRC in an average-risk cohort.
Thermo Fisher Scientific, AstraZeneca to Develop Solid Tissue and Blood-Based CDx Test
The firms will develop the NGS-based CDx for non-small cell lung cancer drug Tagrisso using the Oncomine Dx Express Test on the Genexus Dx System.
DermTech Stock Soars on News of Additional Coverage for Melanoma Detection Test
The molecular diagnostics firm said two payors with 1.2 million members in New York and Hawaii will cover DermTech's noninvasive testing platform.